EichorEICHOR
Study identifier: NCT04122872 Synced from ClinicalTrials.gov · August 10, 2026
● Study status: RecruitingGISAR

GISAR German Interdisciplinary Sarcoma Registry

Condition: Sarcoma · Sarcoma,Soft Tissue · Sarcoma of Bone  ·  Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

PhaseN/A
Planned participants9000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNoCheck eligibility criteria ↓
Where21 locations

Interested? Contact the study team ↓

For sponsors, CROs & site teams
Professional view of this study — listed sites, countries and recruiting context from the public registry. Everything below is written for patients and caregivers.See where this study is running →

About this study

GISAR has an open and modular setup. It is sought to include as many German sarcoma and CS patients (i.e. sarcoma and CS patients treated in Germany) in the registry as possible. A basic data set should be collected on every included patient). In order to adress specific scientific questions, additionally detailed data can be collected in defined patient groups (e.g. effectiveness / adverse effects of systemic therapies in defined situations) within the context of sub-project add-on modules. This data collection can be prospective or retrospective depending on the sub-project

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Pink, Dr. med.  ·  +49 33631 7  ·  daniel.pink@helios-gesundheit.de

Bianca Zäpf  ·  +49 7601  ·  zaepf.bianca@ikf-khnw.de

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Histological verified bone or soft tissue sarcomas including bone and soft tissue tumors with borderline histological results or with unclear histological dignity like giant cell tumors of the bone (GCTB), desmoid tumors, atypical lipomatous tumors etc. - independent of therapy form and therapy line - or Histological verified sarcomatoid carcinomas/ carcinosarcomas: tumors with histological, cytological, or molecular properties of both epithelial tumors ("carcinoma") and mesenchymal tumors ("sarcoma") - independent of therapy form and therapy line. * Signed informed consent form or equivalent (s. chapter 10) * Age ≥18 years Exclusion Criteria: * none

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (21)

Universitätsklinikum TübingenTübingen, Baden-Wurttemberg, GermanyRecruiting
Universitätsklinikum ErlangenErlangen, Bavaria, GermanyRecruiting
HELIOS Klinikum Bad SaarowBad Saarow, GermanyRecruiting
HELIOS Klinikum Berlin-BuchBerlin, GermanyRecruiting
Vivantes Klinikum Berlin-SpandauBerlin-Spandau, GermanyRecruiting
Universitätsklinikum ErlangenErlangen, GermanyRecruiting
Klinikum Frankfurt HöchstFrankfurt, GermanyRecruiting
Krankenhaus Nordwest KHNWFrankfurt, GermanyRecruiting
Uniklinik FreiburgFreiburg im Breisgau, GermanyRecruiting
Universitätsmedizin GöttingenGöttingen, GermanyRecruiting
Universitätsmedizin GreifswaldGreifswald, GermanyRecruiting
University Hospital Halle (Saale)Halle, GermanyRecruiting

+ 9 more locations — full list on the registry record.

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

TübingenErlangenBad SaarowBerlin

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →